To hear about similar clinical trials, please enter your email below
Trial Title:
Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas
NCT ID:
NCT00419627
Condition:
Colorectal Neoplasms
Stomach Neoplasms
Pancreatic Neoplasms
Breast Neoplasms
Ovarian Cancer
Conditions: Official terms:
Neoplasms
Breast Neoplasms
Colorectal Neoplasms
Pancreatic Neoplasms
Stomach Neoplasms
Conditions: Keywords:
proteomics of solid tumors
Study type:
Observational
Overall status:
Unknown status
Study design:
Time perspective:
Prospective
Summary:
The purpose of this study is to evaluate the presence of proteins in solid tumors which
may lead to an immune response
Detailed description:
The main objective of the study is to evaluate which proteins are presented by the HLA
complex of solid tumors. Secondary objectives include to evaluate whether an immune
response specific to these proteins has actually been provoked and whether there is a
similar immune response following recurrence. Real specimens will be evaluated using PCR
and mass spectrometry.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Patients with adenocarcinoma of breast, colon, rectum, ovary , stomach, pancreas
Exclusion Criteria:
- Withdrawal of consent
- Small specimen which does not allow to retrieve tissue without interfering with
pathologic evaluation
Gender:
All
Minimum age:
N/A
Maximum age:
N/A
Locations:
Facility:
Name:
Hillel Yaffe Medical Center
Address:
City:
Hadera
Zip:
38100
Country:
Israel
Contact:
Last name:
Itamar Ashkenazi, M.D.
Phone:
972-4-6304761
Email:
i_ashkenazi@yahoo.com
Start date:
February 2007
Lead sponsor:
Agency:
Hillel Yaffe Medical Center
Agency class:
Other
Collaborator:
Agency:
Technion, Israel Institute of Technology
Agency class:
Other
Source:
Hillel Yaffe Medical Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT00419627
